103 related articles for article (PubMed ID: 25694319)
1. Health economics in clinical research.
Manns BJ
Methods Mol Biol; 2015; 1281():315-30. PubMed ID: 25694319
[TBL] [Abstract][Full Text] [Related]
2. The role of health economics within clinical research.
Manns BJ
Methods Mol Biol; 2009; 473():235-50. PubMed ID: 19160742
[TBL] [Abstract][Full Text] [Related]
3. Evidence-Based Decision Making 7: Health Economics in Clinical Research.
Manns BJ
Methods Mol Biol; 2021; 2249():501-516. PubMed ID: 33871861
[TBL] [Abstract][Full Text] [Related]
4. Review: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force.
Goettsch WG; Enzing J
Value Health; 2014; 17(1):1-2. PubMed ID: 24438710
[No Abstract] [Full Text] [Related]
5. Health economics in drug development: efficient research to inform healthcare funding decisions.
Hall PS; McCabe C; Brown JM; Cameron DA
Eur J Cancer; 2010 Oct; 46(15):2674-80. PubMed ID: 20655197
[TBL] [Abstract][Full Text] [Related]
6. Conducting clinical trials-costs, impacts, and the value of clinical trials networks: A scoping review.
Bentley C; Cressman S; van der Hoek K; Arts K; Dancey J; Peacock S
Clin Trials; 2019 Apr; 16(2):183-193. PubMed ID: 30628466
[TBL] [Abstract][Full Text] [Related]
7. [A changing medical and economic world: complex diseases and interest in economic evaluation of health technologies].
Hiligsmann M; Reginster JY
Rev Med Liege; 2012; 67(5-6):258-62. PubMed ID: 22891476
[TBL] [Abstract][Full Text] [Related]
8. Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force.
Husereau D; Drummond M; Petrou S; Carswell C; Moher D; Greenberg D; Augustovski F; Briggs AH; Mauskopf J; Loder E;
Value Health; 2013; 16(2):231-50. PubMed ID: 23538175
[TBL] [Abstract][Full Text] [Related]
9. Economic evaluation in critical care medicine.
Cox HL; Laupland KB; Manns BJ
J Crit Care; 2006 Jun; 21(2):117-24. PubMed ID: 16769454
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness analysis in relation to budgetary constraints and reallocative restrictions.
Adang E; Voordijk L; Jan van der Wilt G; Ament A
Health Policy; 2005 Oct; 74(2):146-56. PubMed ID: 16153475
[TBL] [Abstract][Full Text] [Related]
11. Budgeting in health care systems.
Maynard A
Eff Health Care; 1984; 2(2):41-9. PubMed ID: 10269645
[TBL] [Abstract][Full Text] [Related]
12. Role of the anesthesiologist in the wider governance of healthcare and health economics.
Martin J; Cheng D
Can J Anaesth; 2013 Sep; 60(9):918-28. PubMed ID: 23820969
[TBL] [Abstract][Full Text] [Related]
13. Economic evaluation in cardiology.
Maniadakis N; Vardas P; Mantovani LG; Fattore G; Boriani G
Europace; 2011 May; 13 Suppl 2():ii3-8. PubMed ID: 21518746
[TBL] [Abstract][Full Text] [Related]
14. Which cancer clinical trials should be considered for economic evaluation? Selection criteria from the National Cancer Institute of Canada's Working Group on Economic Analysis.
Evans WK; Coyle D; Gafni A; Walker H;
Chronic Dis Can; 2003; 24(4):102-7. PubMed ID: 14733759
[TBL] [Abstract][Full Text] [Related]
15. Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis.
Mauskopf JA; Sullivan SD; Annemans L; Caro J; Mullins CD; Nuijten M; Orlewska E; Watkins J; Trueman P
Value Health; 2007; 10(5):336-47. PubMed ID: 17888098
[TBL] [Abstract][Full Text] [Related]
16. Review of economic methods used in complementary medicine.
Doran CM; Chang DH; Kiat H; Bensoussan A
J Altern Complement Med; 2010 May; 16(5):591-5. PubMed ID: 20804369
[TBL] [Abstract][Full Text] [Related]
17. Health economics in developing countries.
Abel-Smith B
J Trop Med Hyg; 1989 Aug; 92(4):229-41. PubMed ID: 2503621
[TBL] [Abstract][Full Text] [Related]
18. How do we evaluate the economics of health care?
Kumar S; Williams AC; Sandy JR
Eur J Orthod; 2006 Dec; 28(6):513-9. PubMed ID: 17035484
[TBL] [Abstract][Full Text] [Related]
19. Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force.
Sullivan SD; Mauskopf JA; Augustovski F; Jaime Caro J; Lee KM; Minchin M; Orlewska E; Penna P; Rodriguez Barrios JM; Shau WY
Value Health; 2014; 17(1):5-14. PubMed ID: 24438712
[TBL] [Abstract][Full Text] [Related]
20. Decision makers' views on health care objectives and budget constraints: results from a pilot study.
Al MJ; Feenstra T; Brouwer WB
Health Policy; 2004 Oct; 70(1):33-48. PubMed ID: 15312708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
